Cheryl Gault
Chief Operating Officer at Rapport Therapeutics, Inc.
Net worth: 2 514 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Bredt | M | - |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 2 years |
| Julie McHugh | F | 59 | 10 years | |
| Abraham Ceesay | M | 46 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 5 years |
| Jon Duane | M | 65 | 5 years | |
| Ronald Silver | M | 42 | 6 years | |
| Steve Paul | M | - |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 2 years |
| Andrew Dreyfus | M | 65 | 8 years | |
| Catherine Moukheibir | F | 64 | 5 years | |
| Marcel Moulaison | M | - | 10 years | |
| Marla Kessler | F | 54 | 5 years | |
| Mike Nanfito | M | - | 12 years | |
| Greg Martini | M | - | 7 years | |
| Raymond Kelleher | M | - |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 1 years |
| James Healy | M | 58 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 1 years |
| Terry-Ann Burrell | F | 47 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | - |
| Jeffrey Tong | M | 48 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | - |
| Michael Shetzline | M | 65 | 5 years | |
| Reid Huber | M | 52 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | - |
| Beth Calitri | F | - | 5 years | |
| Sanjay Mistry | M | - |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | 2 years |
| Jose Matta | M | - |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joe C. Cook | M | 82 | 17 years | |
| Bryan Roberts | M | 57 | 15 years | |
| Jason Rickard | M | 53 | 11 years | |
| Gina Consylman | F | 52 | 7 years | |
| James M. DeTore | M | 59 | 11 years | |
| Terry McGuire | M | 68 | 21 years | |
| Brian M. Cali | M | - | 21 years | |
| Peter Hecht | M | 60 | 21 years | |
| Douglas Williams | M | 66 | 5 years | |
| Michael Higgins | M | 61 | 11 years | |
| Mark Ragosa | M | 50 | 2 years | |
| Kelly MacDonald | F | 40 | 8 years | |
| George Conrades | M | 85 | 11 years | |
| Mark Mallon | M | 61 | 2 years | |
| David Evans Shaw | M | 71 | 10 years | |
| Edward Owens | M | 77 | 9 years | |
| Christopher T. Walsh | M | 80 | 14 years | |
| Lawrence Olanoff | M | 72 | 7 years | |
| David Ebersman | M | 54 | 6 years | |
| Marsha Fanucci | F | 70 | 10 years | |
| Amy Schulman | F | 63 | 2 years | |
| Gina Bornino Miller | F | 63 | 13 years | |
| Mark Currie | M | 69 | 17 years | |
| Lisa Fiering | F | - | 3 years | |
| Xiao Bing Li | M | 56 | 2 years | |
| Michelle Robertson | F | 57 | 3 years | |
| Christina Isacson | F | 45 | 6 years | |
| Rhonda M. Chicko | F | 58 | 10 years | |
| Thomas Graney | M | 60 | 3 years | |
| Jonathan Rosin | M | - | 7 years | |
| John Crowley | M | 51 | 1 years | |
| Christopher Wright | M | 58 | - | |
| Michael Mendelsohn | M | 69 | 4 years | |
| Michael L. Hall | M | 62 | - | |
| Lisa Adler | F | - | - | |
| Robert Lippe | M | 59 | 3 years | |
| William I. Huyett | M | 68 | 2 years | |
| Jeffrey M. Johnston | M | - | 11 years | |
| Mark D. Plinio | M | 57 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 60 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cheryl Gault
- Personal Network